Table 1.
Characteristic | Participants (N = 109) |
---|---|
Female, No. (%) | 65 (60) |
Age group, No. (%) | |
< 40 y | 12 (11) |
41 to 50 y | 23 (21) |
51 to 64 y | 48 (44) |
65 to 79 y | 23 (21) |
≥ 80 y | 3 (3) |
Race, No. (%) | |
Asian | 1 (1) |
Black or African American | 29 (27) |
White | 79 (72) |
Hispanic or Latino ethnicity, No. (%) | 1 (1) |
Treatment status in the past month, No. (%) | |
None (ie, posttreatment follow-up) | 32 (71) |
Undergoing treatment | 77 (29) |
Cancer type, No. (%) | |
Breast cancer | 29 (27) |
Colorectal cancer | 7 (6) |
Gynecologic cancer | 16 (15) |
Hematologic cancer | 8 (7) |
Lung cancer | 11 (10) |
Prostate | 24 (22) |
Unknown or othera | 14 (13) |
Other cancer types included bladder cancer, head or neck cancer, mesothelioma, renal cell carcinoma, thymoma, and thyroid cancer.